Medial EarlySign (earlysign.com), a pioneering company developing Artificial Intelligence (AI) based clinical predictive analytics, announced today the signing of a new partnership with Roche, which will focus on innovative, evidence-based solutions for early detection of lung cancer.
July 7, 2022
· 3 min read